Intravitreal Ocriplasmin for Vitreomacular Traction Syndrome and small Macular Holes
A novel drug that is injected into the eyeball under local anesthetic, Ocriplasmin is effective in relieving vitreous traction at the macular. It is also effective in closing small macular holes in selected patients. This approach obviates the need for surgery in patients who had vision distortion or vision loss due to these two conditions. Your surgeon will determine if you are a suitable patient for such therapy.